Lipidomics in Health & Disease

Methods & Application
Herausgegeben:Wang, Xiangdong; Wu, Duojiao; Shen, Huali

• Gebundenes Buch

Produktbeschreibung

This volume covers the emerging area of science, Clinical Lipidomics, which is the application of lipidology to the understanding of physiological and pathophysiological changes of lipidomes, with a special focus on lipidomic profiles in human diseases.

Lipidomics is widely used to map lipid molecular species in a biological system. Clinical lipidomic analysis has demonstrated the comprehensive characterization of molecular lipids in various severities, durations, and therapies as a critical tool in identification and validation of disease-specific biomarkers.

This volume on Clinical Lipidomics will add to the literature and help advance the knowledge of the pathogenesis, diagnosis, prevention and treatment of diseases.

Produktdetails

• Translational Bioinformatics 14
• Verlag: Springer / Springer Nature Singapore / Springer, Berlin
• Artikelnr. des Verlages: 978-981-13-0619-8
• 1st ed. 2018
• Seitenzahl: 212
• Erscheinungstermin: 18. September 2018
• Englisch
• Abmessung: 241mm x 160mm x 17mm
• Gewicht: 496g
• ISBN-13: 9789811306198
• ISBN-10: 9811306192
• Artikelnr.: 52438214

Autorenporträt

Dr. Xiangdong Wang is Distinguished Professor at Zhongshan Hospital Fudan University.

Inhaltsangabe

Chapter 1. Clinical Lipidomics: A Critical Approach for Disease Diagnosis and Therapy.- Chapter 2. The role of lipid metabolism in the development of lung cancer.- Chapter 3. Bioinformatics of Embryonic Exposures: Lipid Metabolism and Gender as Biomedical Variables.- Chapter 4. An Evaluation of Multivariate Data Analysis Models for Lipidomic Parameters from Patients with Metabolic Syndrome Undergoing Remedial Treatment.- Chapter 5. Lipidomics in carotid artery stenosis: further understanding of pathology and treatment.- Chapter 6. Metabolomics of Immunity and Its Clinical Applications.- Chapter 7. Urinary Lipidomics.- Chapter 8. Breast cancer and lipid metabolism.- Chapter 9. Association of circulating oxidized lipids with cardiovascular outcomes.- Chapter 10. Lipidomics: Mass Spectrometry Based Untargeted Profiling and False Positives.- Chapter 11. Phospholipid and Phospholipidomics in Health and Diseases.